ask="11.95"
ask_size="300"
average_daily_volume="17289"
bid="4.55"
bid_size="100"
book_value="0.44"
change="+0.17"
change_from_200_day_moving_average="-0.08"
change_from_50_day_moving_average="-0.58"
change_from_52_week_high="-2.80"
change_From_52_week_low="2.05"
change_in_percent="+3.39%"
close="5.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-0.47"
ex_dividend_date="N/A"
float_shares="3301000"
high="5.25"
high_52_weeks="7.95"
last_trade_date="2/24/2017"
last_trade_price="5.15"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.00"
low_52_weeks="3.10"
market_capitalization="147.85M"
moving_average_200_day="5.23"
moving_average_50_day="5.73"
name="OncoCyte Corporation"
notes="N/A"
one_year_target_price="8.88"
open="5.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.61%"
percent_change_from_50_day_moving_average="-10.20%"
percent_change_from_52_week_high="-35.22%"
percent_change_from_52_week_low="+66.13%"
previous_close="4.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.27"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="4.26"
stock_exchange="ASE"
symbol="OCX"
volume="8670"
weeks_range_52="3.10 - 7.95"
